Objective: Accumulated evidence suggests that the primary cause of poor outcome after subarachnoid hemorrhage is not only cerebral arterial narrowing but also early brain injury. Our objective was to determine the effect of recombinant osteopontin, a pleiotropic extracellular matrix glycoprotein, on early brain injury after subarachnoid hemorrhage in rats.
A neurysmal subarachnoid hemorrhage (SAH) is a common and devastating neurologic disorder (1) . Cerebral vasospasm has been believed to be a leading cause of mortality and morbidity (2) . Recent randomized clinical trials, however, showed that clazosentan significantly reduced angiographic vasospasm but failed to improve long-term neurologic outcome (3, 4) . This means that the treatment efforts targeting only angiographic vasospasm might not be enough to achieve a better outcome. Thus, new research efforts have focused on clarifying the pathophysiology of early brain injury (EBI) after SAH, and on developing protective strategies against it (5) .
Osteopontin (OPN) is a secreted extracellular matrix glycoprotein that is involved in both physiologic and pathologic processes in a wide range of tissue (6) . The biological functions of OPN are highly variable, and often seemingly contradictory depending on the biological scenario surrounding its induction (7) . However, there is compelling evidence that OPN can, in a variety of situations, help cells survive an otherwise lethal insult (8) . For example, endogenous OPN induction has consistently been found to have protective effects on ischemic injuries involving the brain and other organs (9, 10) . Furthermore, the administration of recombinant OPN (r-OPN) markedly reduced the infarct size via anti-apoptotic actions in a transient focal cerebral ischemia model of mice (11) . To date, however, no experimental studies have investigated the effect of r-OPN on EBI or blood-brain barrier (BBB) disruption after SAH. Here, we report a beneficial effect of r-OPN treatment on EBI after SAH.
MATERIALS AND METHODS
All protocols were approved by the Institutional Animal Care and Use Committee of Loma Linda University. The animals were cared for in accordance with the Guidelines of the Committee.
Experimental Model of SAH and Study Protocol
The endovascular perforation model of SAH was produced in male adult Sprague-Dawley rats (300 to 370 g; Harlan, Indianapolis, IN) as previously described with slight modifications (12) (13) (14) . Briefly, rats were anesthetized with 3% isoflurane in 60%/40% medical air/oxygen in a small animal anesthesia induction box, followed by the subcutaneous injection of atropine (0.1 mg/kg). The animals were trans-orally intubated and the respiration was maintained with a small rodent respirator (Harvard Apparatus, Holliston, MA). Anesthesia was maintained with 2% to 3% isoflurane in 60%/40% medical air/oxygen. Blood pressure and blood gas were measured via the left femoral artery. Rectal temperature was kept at approximately 37°C with an electric heating pad. After exposing the left common carotid artery, external carotid artery, and internal carotid artery, the external carotid artery was ligated, cut, and shaped into a 3-mm stump. A sharpened 4-0 monofilament nylon suture was advanced rostrally into the internal carotid artery from the external carotid artery stump until resistance was felt (15 to 18 mm from the common carotid bifurcation) and then pushed 3 mm further to perforate the bifurcation of the anterior and middle cerebral arteries. Immediately after puncture, the suture was withdrawn into the external carotid artery stump, and the internal carotid artery was reperfused to produce SAH. Shamoperated rats underwent the identical procedures except that the suture was withdrawn once resistance was felt, without puncture. The incision was then closed, and rats were housed individually after their recovery from anesthesia. Animals had free access to food and water until euthanization.
One hundred seventy-seven rats were randomly divided into six groups: sham-operated rats treated with vehicle (n ϭ 23) or 0.1 g of r-OPN (n ϭ 17), and SAH rats treated with vehicle (n ϭ 45), 0.1 g of bovine serum albumin (BSA; n ϭ 11), and 0.02 g (n ϭ 39) or 0.1 g (n ϭ 42) of r-OPN. Neurologic scores and body weight were evaluated before and after the SAH production or shamoperation at each interval of 24 hrs until they were killed. At time of kill, high-resolution pictures of the base of the brain depicting the circle of Willis and basilar arteries were taken for assessing the severity of SAH under ice cooling. The brain water content measurements and Western blot analyses were performed at 24 hrs and BBB permeability was determined at both 24 and 72 hrs after surgery.
Neurologic Scoring
Neurologic scores were blindly evaluated as previously described (13) . The evaluation consists of six tests that can be scored 0 to 3 or 1 to 3. These six tests include: spontaneous activity; symmetry in the movement of all four limbs; forepaw outstretching; climbing; body proprioception; and response to whisker stimulation. The maximum score is 18 and the minimum score is 3. Higher scores indicate greater function.
Severity of SAH
The severity of SAH was blindly assessed using the high-resolution photographs as previously described (13) . The SAH grading system was as follows: the basal cistern was divided into six segments, and each segment was allotted a grade from 0 to 3 depending on the amount of subarachnoid blood clot in the seg-ment; grade 0, no subarachnoid blood; grade 1, minimal subarachnoid blood; grade 2, moderate blood clot with recognizable arteries; and grade 3, blood clot obliterating all arteries within the segment. The animals received a total score ranging from 0 to 18 after adding the scores from all six segments.
Intracerebroventricular Infusion
Rats were placed in a head holder under 2% to 3% isoflurane anesthesia. The needle of a 10-L Hamilton syringe (Microliter #701; Hamilton Company, Reno, NV) was inserted through a burr hole perforated on the skull into the left lateral ventricle using the following coordinates relative to bregma: 1.5 mm posterior; 1.0 mm lateral; 3.2 mm below the horizontal plane of bregma (15) . Sterile saline vehicle (1 L), BSA (0.1 g in 1 L; EMD Chemicals, La Jolla, CA), or mouse r-OPN (0.02 or 0.1 g in 1 L; EMD Chemicals) was automatically infused at a rate of 0.1 L/ minute irrespective of the animal's body weight at 1 hr before the SAH production or shamoperation. The needle was removed 10 mins after finishing of an infusion, and the burr hole was quickly plugged with a bone wax.
Brain Water Content
After killing rats, brains were immediately divided into the right and left cerebral hemispheres, brain stem, and cerebellum, and they were weighed (wet weight). Brain specimens were dried in an oven at 105°C for 72 hrs and weighed again (dry weight). The following formula was used to calculate the percentage of water content: ([wet weight Ϫ dry weight]/wet weight) ϫ 100% (16) .
BBB Permeability
At 24 or 72 hrs after surgery, Evans blue dye (2%; 5 mL/kg) was injected over 2 mins into the left femoral vein and allowed to circulate for 60 mins. Under deep anesthesia, rats were killed by intracardial perfusion with phosphate-buffered saline, and brains were removed and divided into the same regions as the water content study. Brain specimens were weighed, homogenized in 1 mL of phosphatebuffered saline, and centrifuged at 15,000g for 30 mins. Then, 0.6 mL of the resultant supernatant was added to an equal volume of trichloroacetic acid. After overnight incubation at 4°C and centrifugation at 15,000g at 4°C for 30 mins, the supernatant was taken for spectrophotometric quantification of extravasated Evans blue dye at 615 nm as previously described (16) .
Western Blot Analyses
Western blot analysis was performed as previously described (12) . Briefly, the whole left (perforation side) cerebral hemispheres were homogenized, and aliquots of each fraction were used to determine the protein concentration of each sample using a detergent compatible assay (Bio-Rad, Hercules, CA). Equal amounts of protein samples (50 g) were loaded on a Tris glycine gel, electrophoresed, and transferred to a nitrocellulose membrane. Membranes were then blocked with a blocking solution, followed by incubation overnight at 4°with the primary antibodies: mouse monoclonal anti-OPN (1:200 
Statistics
Neurologic scores were expressed as median Ϯ 25th to 75th percentiles, and were analyzed using Kruskal-Wallis test, followed by Steel-Dwass multiple comparisons. Other values were expressed as mean Ϯ SD, and chisquare test and repeated-measures analysis of variance with Scheffe correction were used as appropriate. Stepwise linear regression evaluated independent predictors of Evans blue dye extravasation at 72 hrs after SAH. The p Ͻ 0.05 was considered significant.
RESULTS

Exogenous OPN Prevents Disruption of the BBB After SAH
Comparisons of physiologic parameters revealed no significant differences among the groups (data not shown). None of the sham-operated rats died within the 72-hr observation period. In SAH rats, the mortality in 0.1 g of r-OPN treatment group (11.9%, 5 of 42 rats) tended to be lower but was not significantly different from the other groups (17.8%, 8 of 45 rats; 18.2%, 2 of 11 rats; and 17.9%, 7 of 39 rats; in vehicle, BSA, and 0.02 g of r-OPN treatment groups, respectively). The average SAH grading score was 10.8 Ϯ 4.1 at 24 hrs (n ϭ 88) and 7.6 Ϯ 4.8 at 72 hrs (n ϭ 27) after SAH. Because the severity of brain injuries in the endovascular perforation model of SAH is correlated with SAH grading scores (13, 14) , SAH was placed into two categories, mild (a total score of Յ9 at 24 hrs, n ϭ 27; or Յ6 at 72 hrs after SAH, n ϭ 9) and severe (a total score of Ն10 at 24 hrs, n ϭ 61; or Ն7 at 72 hrs after SAH, n ϭ 18). Vehicle-treated mild SAH rats (n ϭ 5) did not significantly increase Evans blue dye extravasation compared with sham-operated rats (n ϭ 12) at 24 hrs after SAH (Data not shown). Thus, further anal-ysis was performed on severe SAH rats, in which the vessel rupture was consistently at the bifurcation of the anterior and middle cerebral arteries.
The average SAH grading score in severe SAH rats was similar among the groups in each analysis (12.4 Ϯ 1.9, 12.8 Ϯ 1.2, 13.6 Ϯ 2.5, and 12.3 Ϯ 2.2 in the vehicle, BSA, 0.02, and 0.1 g of r-OPN treatment groups at 24 hrs; 9.8 Ϯ 1.7, 11.2 Ϯ 1.2, and 9.7 Ϯ 2.2 in the vehicle, 0.02, and 0.1 g of r-OPN treatment groups at 72 hrs after SAH). This indicates similar injury among compared groups and suggests that differences in outcomes are the result of different treatments.
Administration of 0.1 g of r-OPN before SAH significantly prevented a loss in body weight and neurologic impairment compared with the vehicle-treated and BSA-treated SAH groups at 24 and 72 hrs after SAH (Fig. 1 ). SAH caused a significant increase in Evans blue dye extravasation in all brain regions, which was significantly attenuated by both dosages of r-OPN treatment in the bilateral cerebral hemispheres at 24 hrs after SAH (Fig. 2) . As a control, we injected BSA, a protein with an equivalent weight to r-OPN, and excluded the possibility of a nonspecific response to intracerebroventricular protein injection. At 72 hrs after SAH, Evans blue dye extravasation in the left cerebral hemisphere and brain stem was still elevated in vehicle-treated and BSA-treated SAH rats, and a significant linear correlation was observed between Evans blue dye extravasation in the left cerebral hemisphere and neurologic scores (r ϭ Ϫ.716; p Ͻ .005). In linear regression analysis, however, r-OPN treatment, but not neurologic and SAH grading scores, was the only independent factor associated with Evans blue dye extravasation at 72 hrs after SAH (F ratio ϭ 20.7; p Ͻ .005).
Similarly, increases in brain water content after SAH were significantly reduced by r-OPN treatment in the bilateral cerebral hemispheres at 24 hrs after SAH (Fig.  3) . The r-OPN had no effects on body weight loss, neurologic impairment, Evans blue dye extravasation, and brain water content in sham-operated rats (Figs. 1-3 ).
Exogenous OPN Prevents MMP-9 Induction and Tissue Inhibitor of MMP-1 Reduction After SAH
Western blot analysis of the left cerebral hemisphere showed that SAH significantly increased active MMP-9 expression and decreased its corresponding inhibitor TIMP-1 expression, which were significantly inhibited by r-OPN treatment at 24 hrs after SAH (Fig. 4, A and  B) . Post-SAH degradation of laminin and zona occludens-1, which are basement membrane and inter-endothelial tight junction proteins of cerebral microvessels, respectively, and substrates of MMP-9, was also significantly suppressed by r-OPN treatment (Fig. 4, C and D) . A significant linear correlation was observed between the active MMP-9 level and the TIMP-1 (r ϭ Ϫ.914; p Ͻ .0001), laminin (r ϭ Ϫ.686; p Ͻ .005) and zona occludens-1 (r ϭ Ϫ.724; p Ͻ .005) levels.
Exogenous OPN Does Not Inhibit IL-1␤ Induction But Suppresses Nuclear Factor-B Activation After SAH
Cleaved IL-1␤ levels were significantly elevated in SAH rats compared with sham-operated rats, but r-OPN did not suppress cleaved IL-1␤ levels (Fig. 5) . In vehicle-treated SAH rats, an increased phosphorylation of anti-phospho-IB kinase ␣/␤ and IB-␣, along with a degradation of IB-␣, was shown, demonstrating the NF-B activation (17) . This activation was significantly inhibited by r-OPN treatment (Fig. 6) , and phosphorylated IB-␣ was significantly correlated with active MMP-9 levels (r ϭ 0.864, p Ͻ 0.0001).
Exogenous OPN Suppresses Endogenous OPN Induction After SAH. SAH caused endogenous OPN induction (Fig.  7) . The r-OPN treatment did not change endogenous OPN levels in the shamoperated rats but significantly suppressed endogenous OPN induction after SAH. These findings may reflect the decreased brain damage after r-OPN treatment.
DISCUSSION
In this study, pre-SAH intracerebroventricular administration of r-OPN demonstrated significant prevention against EBI as measured by reductions in post-SAH loss in body weight, neurologic impairment, brain edema, and BBB disruption. This protection was provided by r-OPN-mediated deactivation of NF-B activity, thereby improving the balance between proteolytic (MMP-9) and matrixstabilizing factors (TIMP-1).
A key pathologic manifestation of post-SAH EBI is an increase in BBB permeability, which leads to vasogenic edema. Global cerebral edema, or BBB dysfunction, has been described as an independent risk factor for poor outcome after SAH (18) . BBB dysfunction may allow greater influx of blood-borne cells and substances into brain parenchyma, thus amplifying inflammation, leading to further parenchymal damage and edema formation (19) . Post-SAH BBB breakdown, however, is a transient phenomenon and a functional recovery may ensue, although the intrinsic mechanisms to reverse BBB disruption are unknown. OPN is induced in response to tissue injuries or inflammation, and may play a role in the maintenance of tissue homeostasis and the induction of tissue repair in a variety of situations (8 -10) . Our unpublished data also showed that the blockage of endogenous OPN induction aggravated post-SAH neurologic impairment and BBB disruption. These findings suggest that OPN may represent a naturally occurring protective factor against EBI after SAH, supporting the results in this study.
Accumulated evidence supports a role for MMP-9 in the early BBB disruption of neuroinflammatory diseases or stroke (20, 21) . MMP-9 degrades the extracellular matrix of cerebral microvessel basal lamina, including collagen IV, laminin, fibronectin, and inter-endothelial tight junction proteins such as zona occludens-1, causing BBB disruption after SAH (16, 21) . A balanced interaction between MMP-9 and TIMP-1 may determine the severity of BBB disruption and neuronal apoptosis after insults (22) . The activation of NF-B has been detected in the cerebral cortices adjacent to SAH (19) , and is known to directly regulate the transcription of MMP-9 and TIMP-1 in addition to orchestrating the inflammatory cascade (23, 24) .
OPN regulates the bioavailability of MMP, although the effects exerted by OPN on MMP differ depending on cell types, receptor interactions, post-translational modifications, and the phosphorylation state of OPN (7, 25, 26) . For example, OPN alone has no effect on MMP-9 activity or expression, nor does it affect NF-B activity in various non-tumor culture cells (27) (28) (29) ; however, OPN increased MMP-9 activity in human new- born aortic smooth muscle cells in the presence of platelet-derived growth factor-BB , as well as in many tumor cells (26, 28) . There are also several studies demonstrating the role of OPN as an inhibitor of MMP-9 and NF-B activity, such as the ability of OPN to inhibit IL-1␤-stimulated increases in activities and expression of MMP-9 in adult rat cardiac fibroblasts (29) , and the ability of OPN to prevent NF-B activation and nitric oxide synthesis in IL-1␤ and endotoxin-treated non-tumor cells (27, 30) . Our data also demonstrate the role of OPN as an inhibitor of MMP-9 and NF-B activity in the presence of proinflammatory cytokines, in our case IL-1␤ elevation after SAH. Given these data we hypothesize that the inhibitory effects of OPN on MMP-9 and NF-B activities may be observed only in the presence of proinflammatory cytokines.
IL-1␤ has been repeatedly reported to be induced in the brain after SAH and cause brain injuries (31, 32) . IL-1␤induced MMP-9 secretion from astrocytes is critically dependant on NF-B signaling pathways (33) , and the direct inhibition of NF-B prevented IL-1␤-stimulated increases in MMP-9 expression and activity in adult rat cardiac fibroblasts (17) . Our study demonstrates similar effects in an in vivo model. However, our study showed that the inactivation of NF-B by OPN had no effect on IL-1␤ levels. Previous experiments using OPN knockout mice showed increased IL-1␤ gene expression in ischemic brain injury (10), whereas others have shown that reducing NF-B activity reduced IL-1␤ levels after myocardial infarction (24) . Our diverging findings may be explained by IL-1␤ induction via NF-B-independent mechanisms, such as post-SAH sympathetic activation or catecholamine release (34, 35) . However, oxidative stress also up-regulates MMP-9 levels in brain (20) . Because the oxidative stress-dependent MMP-9 induction is accompanied by NF-B activation (36) , OPN might inactivate NF-B by reducing oxidative stress (6, 9) . In this regard, further studies are needed.
This study had some limitations. First, rats were anesthetized with isoflurane, which has been shown to have neuroprotection (37) . Thus, a combined effect of r-OPN and isoflurane cannot be excluded. Second, r-OPN was administered via an intracerebroventricular injection as a pretreatment. This diminishes the translational significance of the study, and the effects of post-treatment and other ad-ministration methods should be examined before clinical trials. Third, we did not examine the effect of r-OPN on vasospasm or cerebral blood flow that might contribute to neurologic improvement, although OPN has not been reported to affect vessel diameters. Considering pleiotropic effects of OPN, it would be worth examining if OPN has protective effects on post-SAH pathology other than the BBB protection observed in this study.
In conclusion, we demonstrate for the first time that r-OPN treatment prevented EBI or BBB disruption after SAH. We feel that r-OPN treatment is promising, and our findings warrant more research.
